During the past decade, Pacific Clinical Research Medical Group conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 16 clinical trials were completed, i.e. on average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 13 clinical trials were completed. i.e. 118.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pacific Clinical Research Medical Group" #1 sponsor was "Naurex, Inc, an affiliate of Allergan plc" with 6 trials, followed by "Pfizer" with 6 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 4 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored and "Forest Laboratories" with 4 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pacific Clinical Research Medical Group" #1 collaborator was "Otsuka America Pharmaceutical" with 2 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "Neumora Therapeutics, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Pacific Clinical Research Medical Group" are "Major Depressive Disorder" (12 trials), "Depressive Disorder, Major" (8 trials), "Generalized Anxiety Disorder" (5 trials), "Depression" (3 trials) and "Schizophrenia" (3 trials). Many other conditions were trialed in "Pacific Clinical Research Medical Group" in a lesser frequency.

Most popular intervention types in "Pacific Clinical Research Medical Group" are "Drug" (45 trials), "Other" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Rapastinel" (6 trials), "placebo" (3 trials), "BMS-820836" (2 trials) and "Fluoxetine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pacific Clinical Research Medical Group" are 43 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Pacific Clinical Research Medical Group". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 33 completed trials in Pacific Clinical Research Medical Group, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Pacific Clinical Research Medical Group, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".